Citations

Showing 10 of 108094 citations.

Developmental Dynamics in Real Time
Carmichael, Stephen W.

Mayo Clinic

Microscopy Today | May 22, 2018 | Volume: 17 | Issue: 3 | Pages: 3-5

10.1017/s1551929500050021 Get It

Abstract Embryologic development is a dynamic process that has been previously studied by examining static (usually chemically-fixed) specimens at different time periods and then extrapolating results by assembling a series of static images. Recently, Amy McMahon, Willy Supatto, Scott Fraser, and Angelike Stathopoulos have developed new methods to look at developmental migration patterns in real time. They used an optimized imaging approach and quantitative methods to analyze a two hour period during which gastrulation occurred in the embryos of fruitflies (Drosophila). Specifically, they characterized the complex interactions between cells of the ectoderm and mesoderm by tracking the movements of over 1,500 cells, which involved the analysis of over 100,000 cell positions for each embryo!
Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery
Holmes, David R. , Melduni, Rowlens M. , Johnsrud, Daniel O. , Sangaralingham, Lindsey R. , Shah, Nilay D. , Yao, Xiaoxi , Gersh, Bernard J. , Noseworthy, Peter A.

Mayo Clinic

JAMA | May 22, 2018 | Volume: 319 | Issue: 20 | Pages: 2116

10.1001/jama.2018.6024 | PMID 29800182 Get It

Faculty Opinions recommendation of Six-Year Changes in Physical Activity and the Risk of Incident Heart Failure: ARIC Study.
Borlaug, Barry A.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | May 22, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.732592406.793545867 Get It

A Survey of Patient and Partner Outcome and Treatment Preferences in Mild Cognitive Impairment
Chandler, Melanie , Fields, Julie A. , Aakre, Jeremiah A. , Aakre, Jeremiah, Locke, Dona E.C. , Smith, Glenn E.

Mayo Clinic

Journal of Alzheimer's Disease | May 22, 2018 | Volume: 63 | Issue: 4 | Pages: 1459-1468

10.3233/jad-171161 | PMID 29843239 Get It

Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume
Đenić, Aleksandar , Mathew, Jerry, Nagineni, Venkata V., Thompson, R. Houston, Leibovich, Bradley C. , Lerman, Lilach O. , Alexander, Mariam P., Augustine, Joshua J. , Kremers, Walter K. , Rule, Andrew D , Denic, Aleksandar , Lieske, John C. , Augustine, Joshua , Rule, Andrew D. , Kremers, Walter K

Mayo Clinic

Journal of the American Society of Nephrology | May 22, 2018 | Volume: 29 | Issue: 7 | Pages: 1960-1969

10.1681/asn.2017121305 | PMID 29789431 Get It

Background Glomerular volume increases when demand exceeds nephron supply, which may lead to glomerulosclerosis. It is unclear if determinants of glomerular volume are consistent between populations that differ by severity of comorbidities. Methods We studied kidney biopsy specimens from living kidney donors ( n =2453) and patients who underwent radical nephrectomy for a renal tumor ( n =780). We scanned specimen sections into high-resolution digital images, manually traced glomerular profiles, and calculated mean glomerular volumes using the Weibel–Gomez stereologic formula (separately for nonsclerosed glomeruli and globally sclerosed glomeruli). We then assessed the relationship of glomerular volume with age, clinical characteristics, and nephrosclerosis on biopsy specimen. Results Compared with kidney donors, patients with tumors were older and more frequently men, obese, diabetic, or hypertensive, had more glomerulosclerosis and interstitial fibrosis on biopsy specimen, and had 12% larger nonsclerosed glomeruli ( P <0.001). In both populations, male sex, taller height, obesity, hypertension, and proteinuria associated with larger nonsclerosed glomeruli to a similar extent. In patients with tumors, diabetes, glomerulosclerosis >25%, and interstitial fibrosis >25% also associated with larger nonsclerosed glomeruli. Independent clinical predictors of larger nonsclerotic glomeruli were family history of ESRD, male sex, taller height, obesity, diabetes, and proteinuria. After adjustment for these characteristics, nonsclerotic glomerular volume did not differ between populations and was stable up to age 75 years, after which it decreased with age. Many of these findings were also evident with globally sclerotic glomerular volume. Conclusions Characteristics associated with glomerular volume are consistent between patient populations with low and high levels of comorbidity.
Balloon Occlusion Testing to Assess Retinal Collateral and Predict Visual Outcomes in the Management of a Fusiform Intraorbital Ophthalmic Artery Aneurysm: Technical Note and Literature Review
Sattur, Mithun G. , Welz, Matthew E., Miller, Jeffrey W. , Bendok, Bernard R. , Miller, Jeffrey

Mayo Clinic

Operative Neurosurgery | May 22, 2018 | Volume: 16 | Issue: 2 | Pages: E60-E66

10.1093/ons/opy087 | PMID 29790970 Get It

Abstract BACKGROUND AND IMPORTANCE Aneurysms of the ophthalmic artery (OA) within the orbit and optic canal are extremely rare. Given the peripheral location of these aneurysms and the fact that most are fusiform, parent artery occlusion is preferred for symptomatic aneurysms. However, the impact of OA occlusion on vision is not always innocuous. Balloon occlusion testing (BOT) of the OA has the potential to gauge the possibility of visual compromise, in addition to assessing collaterals. While BOT has been assessed for carotid artery occlusion, its role in OA occlusion has not been well defined. CLINICAL PRESENTATION We describe a patient with a 6-mm intracanalicular OA aneurysm who was treated with endovascular coil embolization of the aneurysm and occlusion of the parent artery. We performed a 30-min balloon occlusion test, in which we verified intact visual and neurological function. Collateral vascularity was confirmed. Complete occlusion was achieved and the patient recovered with intact visual and neurological function. We provide a review of literature pertaining to parent artery occlusion of OA aneurysms that occur within optic canal and orbit. A brief note on anatomy of OA and collaterals is provided. CONCLUSION Endovascular parent artery occlusion is an effective treatment for OA aneurysms that occur in optic canal and orbit. Assessment of effect of occlusion on vision is important. BOT can assess this and provide valuable information. Recovery or preservation of visual function is highly dependent on preoperative visual status.
Impact of Personality Disorder Cluster on Depression Outcomes Within Collaborative Care Management Model of Care
George, Merit P., Garrison, Gregory M. , Merten, Zachary, Heredia, Dagoberto , Gonzales, Cesar , Angstman, Kurt B. , Angstman, Kurt B

Mayo Clinic

Journal of Primary Care & Community Health | May 22, 2018 | Volume: 9 | Issue: No issue available | Pages: No page available

10.1177/2150132718776877 | PMID 29785866 Get It

Background: Previous studies have suggested that having a comorbid personality disorder (PD) along with major depression is associated with poorer depression outcomes relative to those without comorbid PD. However, few studies have examined the influence of specific PD cluster types. The purpose of the current study is to compare depression outcomes between cluster A, cluster B, and cluster C PD patients treated within a collaborative care management (CCM), relative to CCM patients without a PD diagnosis. The overarching goal was to identify cluster types that might confer a worse clinical prognosis. Methods: This retrospective chart review study examined 2826 adult patients with depression enrolled in CCM. The cohort was divided into 4 groups based on the presence of a comorbid PD diagnosis (cluster A/nonspecified, cluster B, cluster C, or no PD). Baseline clinical and demographic variables, along with 6-month follow-up Patient Health Questionnaire–9 (PHQ-9) scores were obtained for all groups. Depression remission was defined as a PHQ-9 score <5 at 6 months, and persistent depressive symptoms (PDS) was defined as a PHQ-9 score ≥10 at 6 months. Adjusted odds ratios (AORs) were determined for both remission and PDS using logistic regression modeling for the 6-month PHQ-9 outcome, while retaining all study variables. Results: A total of 59 patients (2.1%) had a cluster A or nonspecified PD diagnosis, 122 patients (4.3%) had a cluster B diagnosis, 35 patients (1.2%) had a cluster C diagnosis, and 2610 patients (92.4%) did not have any PD diagnosis. The presence of a cluster A/nonspecified PD diagnosis was associated with a 62% lower likelihood of remission at 6 months (AOR = 0.38; 95% CI 0.20-0.70). The presence of a cluster B PD diagnosis was associated with a 71% lower likelihood of remission at 6 months (AOR = 0.29; 95% CI 0.18-0.47). Conversely, having a cluster C diagnosis was not associated with a significantly lower likelihood of remission at 6 months (AOR = 0.83; 95% CI 0.42-1.65). Increased odds of having PDS at 6-month follow-up were seen with cluster A/nonspecified PD patients (AOR = 3.35; 95% CI 1.92-5.84) as well as cluster B patients (AOR = 3.66; 95% CI 2.45-5.47). However, cluster C patents did not have significantly increased odds of experiencing persistent depressive symptoms at 6-month follow-up (AOR = 0.95; 95% CI 0.45-2.00). Conclusions: Out of the 3 clusters, the presence of a cluster B PD diagnosis was most significantly associated with poorer depression outcomes at 6-month follow-up, including reduced remission rates and increased risk for PDS. The cluster A/nonspecified PD group also showed poor outcomes; however, the heterogeneity of this subgroup with regard to PD features must be noted. The development of novel targeted interventions for at-risk clusters may be warranted in order to improve outcomes of these patients within the CCM model of care.
Rethinking the prescription of biotin for dermatologic conditions
Kumar, Anagha , França, Katlein , França, Katlein , Kumar, Anagha Bangalore , Lotti, Torello

Mayo Clinic

Dermatologic Therapy | May 22, 2018 | Volume: 31 | Issue: 4 | Pages: e12618

10.1111/dth.12618 | PMID 29786929 Get It

Outcomes of oesophageal self‐dilation for patients with refractory benign oesophageal strictures
Qin, Yi , Sunjaya, Dharma , Myburgh, Sarel J., Sawas, Tarek , Katzka, David A. , Alexander, Jeffrey A. , Halland, Magnus , Qin, Y , Sawas, T , Katzka, D A , Halland, M , Sunjaya, D

Mayo Clinic

Alimentary Pharmacology & Therapeutics | May 22, 2018 | Volume: 48 | Issue: 1 | Pages: 87-94

10.1111/apt.14807 | PMID 29785713 Get It

SummaryBackgroundCurrent management of refractory benign oesophageal strictures with endoscopic dilations and stenting leads to resolution of dysphagia in only 30% of patients. Oesophageal self‐dilation may be an alternative.AimTo evaluate the efficacy and safety of oesophageal self‐dilation at a tertiary referral centre.MethodsWe conducted a retrospective review of patients with refractory benign oesophageal strictures who participated in oesophageal self‐dilation at Mayo Clinic (Rochester, MN, USA) between 2003 and 2017. Clinical data including stricture characteristics, Dakkak and Bennett Dysphagia Score, number and dates of endoscopies, and complications were collected. A two‐tailed paired Student's t test was used to compare the measures of efficacy, with differences considered significant at a 5% probability level.ResultsWe identified 52 patients with refractory strictures treated with self‐dilation. The median number of endoscopic interventions was reduced from 9.5 (range 5‐30) to 0 (range 0‐3) within 12 months before and after self‐dilation, respectively (P < 0.0001). A median intervention‐free interval of 417 days (IQR 256‐756 days) was observed. The mean dysphagia score at baseline was 2.5 (95% CI 2.2‐2.8) and 0.33 (95% CI 0.11‐0.53) after self‐dilation. 23 of 27 (85%) patients who received enteral nutrition prior to self‐dilation had their feeding tubes removed.ConclusionsOesophageal self‐dilation is an effective way of maintaining oesophageal patency in refractory benign oesophageal strictures, with safety comparable to current standard of care. Prospective studies are needed to further validate the role of self‐dilation in treatment of refractory benign oesophageal strictures.
Development of a robust MRI fiducial system for automated fusion of MR‐US abdominal images
Favazza, Christopher , Gorny, Krzysztof R. , Callstrom, Matthew R. , Kurup, A. Nicholas , Washburn, Michael J., Trester, Pamela S. , Fowler, Charles L., Hangiandreou, Nicholas J., Favazza, Christopher P, Kurup, Anil N, Kurup, Anil N

Mayo Clinic

Journal of Applied Clinical Medical Physics | May 22, 2018 | Volume: 19 | Issue: 4 | Pages: 261-270

10.1002/acm2.12352 | PMID 29785834 Get It

AbstractWe present the development of a two‐component magnetic resonance (MR) fiducial system, that is, a fiducial marker device combined with an auto‐segmentation algorithm, designed to be paired with existing ultrasound probe tracking and image fusion technology to automatically fuse MR and ultrasound (US) images. The fiducial device consisted of four ~6.4 mL cylindrical wells filled with 1 g/L copper sulfate solution. The algorithm was designed to automatically segment the device in clinical abdominal MR images. The algorithm's detection rate and repeatability were investigated through a phantom study and in human volunteers. The detection rate was 100% in all phantom and human images. The center‐of‐mass of the fiducial device was robustly identified with maximum variations of 2.9 mm in position and 0.9° in angular orientation. In volunteer images, average differences between algorithm‐measured inter‐marker spacings and actual separation distances were 0.53 ± 0.36 mm. “Proof‐of‐concept” automatic MR‐US fusions were conducted with sets of images from both a phantom and volunteer using a commercial prototype system, which was built based on the above findings. Image fusion accuracy was measured to be within 5 mm for breath‐hold scanning. These results demonstrate the capability of this approach to automatically fuse US and MR images acquired across a wide range of clinical abdominal pulse sequences.